Received 14 December 1999/Returned for modification 28 February
2000/Accepted 26 April 2000
 |
INTRODUCTION |
The outer membrane of a
gram-negative bacterium is a barrier to many antibiotics and host
defense factors (36). This barrier function is due in large
part to structural features of the lipopolysaccharide (LPS) molecules
that make up the outer leaflet of the outer membrane bilayer. In
Escherichia coli and Salmonella enterica, the LPS molecule is conceptually divided into three distinct regions: (i) a
hydrophobic membrane anchor designated lipid A; (ii) a short chain of
sugar residues with multiple phosphoryl substituents, referred to as
the core oligosaccharide; and (iii) a structurally diverse polymer
composed of oligosaccharide repeats, termed the O antigen
(26). The presence of phosphoryl substituents in the heptose
region of the LPS core oligosaccharide is a key structural feature
required for the formation of a stable outer membrane in E. coli and S. enterica (18, 43). Phosphoryl
substituents are postulated to be critical to outer membrane integrity
because their negative charge allows neighboring LPS molecules to be
cross-linked by divalent cations (24, 36). Mutants of
E. coli and S. enterica deficient in core
phosphate exhibit a pleiotropic phenotype called deep rough,
characteristics of which include (i) hypersensitivity to detergents and
hydrophobic antibiotics, (ii) the appearance of phospholipid in the
outer leaflet of the outer membrane bilayer, (iii) leakage of
periplasmic proteins into the culture medium, and (iv) a marked
decrease in the protein content of the outer membrane (reviewed in
references 15 and 29). It has
also been shown that the LPS from phosphate-deficient deep-rough
mutants cannot support the proper folding of some outer membrane
proteins (6).
The gene products involved in core phosphorylation have only recently
been characterized. In E. coli F470, WaaP was shown to be
required for phosphate addition to HepI (43), and this reaction was found to be a prerequisite for the functioning of WaaQ and
WaaY, which are responsible for the addition of HepIII and the
phosphorylation of HepII, respectively (Fig.
1A). Both WaaP and WaaY share limited
similarity with eukaryotic kinases (43) although kinase
activity has yet to be proven. Intuitively, the activity of WaaP is
also a prerequisite for the functioning of the presently unidentified
enzyme responsible for 2-aminoethyl phosphate (PEtN) modification of
the core heptose region (Fig. 1A). Since the E. coli and
S. enterica waaP, waaQ, and waaY gene products are highly conserved (43), these enzymes likely
function the same way in both organisms. Therefore, the LPS core
oligosaccharide of an S. enterica waaP mutant is predicted
to have the structure shown in Fig. 1B.

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Structure of the LPS core oligosaccharide from
S. enterica serovar Typhimurium (20). The inner
core heptose region is highlighted by shading. Genetic determinants for
the modification of the inner core heptose region (conserved between
E. coli and S. enterica) are shown, and they must
function in the following sequence: waaP, waaQ,
and then waaY (43). Abbreviations: Hep,
L-glycero-D-manno-heptose;
Kdo, 3-deoxy-D-manno-oct-2-ulosonic acid; P,
phosphate; PS, polysaccharide. *, the PEtN substitution is
nonstoichiometric but is reportedly present in larger amounts in
PM-resistant mutants of S. enterica (16). (B)
Predicted structure of the LPS core oligosaccharide from CWG304, based
on the function of WaaP in E. coli F470 and its effect on
WaaQ and WaaY activities (43).
|
|
It is noteworthy, however, that the structure of LPS appears to be
dynamic. For example, the LPSs of Helicobacter,
Neisseria, and Haemophilus have all been shown to
undergo phase variation (2, 37, 40). Further, both
Pseudomonas aeruginosa (7) and S. enterica serovar Typhimurium (9, 11, 12) are able to
specifically modify their LPSs in response to environmental cues. One
mechanism by which S. enterica modifies its LPS involves the
PmrA-PmrB two-component regulatory system, which modulates resistance
to numerous cationic antimicrobial compounds, including polymyxin (PM)
(28, 32). Resistance to PM is correlated with the addition
of aminoarabinose to the 4' phosphate of lipid A (9), a
modification that is proposed to decrease the net negative charge of
the LPS molecule and reduce electrostatic interactions between PM and
the outer membrane. Previous studies also suggest, however, that there
is increased PEtN substitution of phosphate residues in the LPS core
heptose region of PM-resistant mutants of S. enterica
(16). This PEtN substitution in the LPS core might also play
a role in PM resistance by decreasing the negative charge of the
bacterial cell surface. The ability of S. enterica and other
pathogens to modulate their LPS suggests that LPS plays both structural
and functional roles in the biology of these organisms.
Given the predicted lack of phosphate in the LPS of an S. enterica waaP mutant (Fig. 1B), it was expected that such a mutant would exhibit hypersensitivity to hydrophobic antimicrobial agents and
other characteristics of the deep-rough phenotype. However, we
envisioned two possible outcomes to sensitivity testing with polycationic antimicrobials such as PM. In one predicted scenario, the
loss of phosphoryl substituents would increase resistance to PM by
decreasing the LPS negative charge, in a similar manner to that
described above for aminoarabinose modifications of lipid A. In the
second scenario, the previously noted sensitivity of waaP
mutants to hydrophobic agents might decrease PM resistance due to
PM-outer membrane interactions of a hydrophobic nature
a possibility
strongly supported by titration calorimetric studies of the PM-LPS
interaction (33). In this paper we address these possibilities and also examine the contribution of core oligosaccharide phosphorylation to the virulence of S. enterica serovar
Typhimurium in a mouse infection model. To determine unequivocally the
role of WaaP in S. enterica virulence, we required a
genetically defined mutant strain. However, earlier "waaP
mutants" of S. enterica were obtained using chemical
mutagenesis and phage selection, and all are reported to be leaky
(18). Therefore, we also report the construction of the
first genetically defined S. enterica waaP mutant and the
chemical characterization of its LPS defect.
 |
MATERIALS AND METHODS |
Bacterial strains.
All strains in this study are derivatives
of S. enterica strain ATCC 14028. Strain JSG435 carries the
pmrA505 allele (28), conferring a
PmrA-constitutive phenotype, and was described previously (10). Strain CWG304 (ATCC 14028 waaP::aacC1) was constructed as
follows. Briefly, waaP (and flanking DNA) was PCR amplified (primers 5'-TGGCATCGCTACCCGAATCT-3' and
5'-TTGGCATAAAGACATGAGAT-3'). The 1.9-kb amplified fragment
was cloned into pBluescript II SK(+) (Stratagene), and sequenced to
ensure error-free amplification. A 48 bp NruI fragment from
the middle of the waaP coding region was then replaced with
the aacC1 gene (a nonpolar cassette conferring gentamicin
resistance) excised with SmaI from plasmid pUCGM
(30). The DNA fragment containing the insertionally
inactivated waaP gene was subsequently cloned into the
suicide delivery vector pMAK705 (13), and chromosomal gene
replacement was performed as described previously (1).
JSG778 was derived by P22 transduction of the
waaP::aacC1 allele into JSG435.
LPS analysis by SDS-polyacrylamide gel electrophoresis
(SDS-PAGE).
LPS was prepared by the method of Hitchcock and Brown
(19). Samples were separated on 10-20% Tricine sodium
dodecyl sulfate (SDS)-polyacrylamide gels (Novex) or standard SDS-12%
polyacrylamide gels (23). Following electrophoresis, the LPS
was visualized by silver staining (35).
Purification of core oligosaccharides.
LPS was isolated from
strains ATCC 14028 and CWG304 by hot phenol-water extraction
(41). The LPS was delipidated by hydrolysis in 2% acetic
acid at 100°C to cleave the acid-labile ketosidic linkage between the
core oligosaccharide and lipid A. Water-insoluble lipid A was removed
by centrifugation, and the polysaccharide-containing supernatant was
passed through a column of Bio-Gel P-2 (1 m by 1 cm) with water as the
eluent. Fractions eluting first contained large amounts of O
polysaccharide, but later fractions contained predominantly core oligosaccharide.
Structural analysis of core oligosaccharides.
31P nuclear magnetic resonance (NMR) spectra of core
oligosaccharides were recorded with a Bruker DRX 400-MHz instrument at 161.98 MHz with ortho-phosphoric acid as the external
reference (0.0 ppm) and with p1 = 30 in the proton-decoupling
mode. Prior to performance of the NMR experiments, the samples were
lyophilized three times in 2H2O (99.9%). The
p2H was adjusted to approximately 8.0 with triethylamine.
Methylation linkage analysis of isolated core oligosaccharides was
performed by the procedure of Ciucanu and Kerek (5). The
permethylated alditol acetate derivatives of the core-containing
samples were characterized by gas-liquid chromatography-mass
spectrometry in the electron impact mode using a column of DB-17
operated isothermally at 190°C for 60 min.
MALDI-TOF mass spectrometry.
LPS was isolated by hot
phenol-water extraction (41), and lipid A was subsequently
obtained by centrifugation after hydrolysis of the LPS in 1% SDS at pH
4.5 (4). Negative-ion matrix-assisted laser desorption
ionization-time-of-flight (MALDI-TOF) mass spectrometry was performed
as described previously (7). Lyophilized lipid A was
dissolved in 5 µl of 5-chloro-2-mercaptobenzothiazole MALDI matrix in
chloroform-methanol (1:1, vol/vol), and 1 µl was then applied to the
sample plate. All MALDI-TOF experiments were performed using a
BiflexIII mass spectrometer (Bruker Daltonics, Inc., Billerica, Mass.).
Antibiotic and detergent sensitivity testing.
SDS and
novobiocin sensitivity testing was performed as described previously
(43). MIC testing for PM susceptibility was performed in
polypropylene microtiter dishes as described by Steinberg et al.
(34).
Mouse virulence studies.
Inbred mouse strains C57BL/6J and
A/J were bred and maintained in the Montreal General Hospital Research
Institute under conditions specified by the Canadian Council on Animal
Care. Mice between 8 and 12 weeks of age were challenged with either
ATCC 14028 or CWG304 by inoculation in the caudal vein with 0.2 ml of
physiological saline containing 102, 103, or
104 CFU of S. enterica. The inoculum of S. enterica was prepared by growing the bacteria for 2 h at
37°C in tryptic soy broth followed by enumeration of the CFU by
incubating serial 10-fold dilutions on tryptic soy agar at 37°C for
16 h (31, 38). The degree of CWG304 virulence was
established in vivo by survival analysis and by measuring the numbers
of CFU in the spleens and livers of surviving mice 21 days
postinoculation. The numbers of viable salmonellae in the spleens and
livers of the infected animals were determined by plating serial
10-fold dilutions of organ homogenates in physiological saline on
tryptic soy agar (8).
Oral and intraperitoneal infections of 16- to 18-g BALB/c mice (Harlan
Sprague-Dawley, Indianapolis, Ind.) were accomplished as follows. For
oral infections, mice deprived of food or water for at least 4 h
were prefed 20 µl of 10% sodium bicarbonate 30 min prior to oral
inoculation with 20 µl of stationary-phase bacteria (~ 3 × 106 to 6 × 106 CFU) diluted in
phosphate-buffered saline. Intraperitoneal infection was performed with
100 µl of stationary-phase bacteria (~ 60 to 100 CFU) diluted in
phosphate-buffered saline. Mouse survival was monitored for three weeks.
 |
RESULTS |
Structure of the LPS core oligosaccharide of a waaP
mutant.
Earlier studies performed with genetically uncharacterized
S. enterica "waaP mutants" indicated that the
core oligosaccharide of such mutant strains was truncated after the
first glucose residue of the outer core (GlcI) (Fig. 1)
(18). To determine whether such was the case for our defined
mutant strain (CWG304), we examined the CWG304 and parent (ATCC 14028)
LPSs by SDS-PAGE (Fig. 2). A typical
ladder-like pattern of smooth LPS bands is visible for the parent
strain and also (although to a lesser extent) for CWG304 (compare lanes
1 and 2 in Fig. 2). Both strains show the same high-molecular-weight
modal cluster of smooth LPS bands (Fig. 2B). However, the CWG304
profile obtained using gradient Tricine SDS-polyacrylamide gels also
shows an intense band that migrates slightly faster than any band in
the parent profile (Fig. 2A, lane 2). These observations indicate that
CWG304 produces a full-length (complete) core capped with O antigen but
that a portion of its LPS molecules is prematurely truncated in the
core. The wild-type LPS banding pattern could be restored to CWG304
(lane 3 in Fig. 2) by complementation with plasmid pWQ909, carrying
waaP from E. coli F470 (43), further
confirming the identical functioning of WaaP in both organisms. This
was the expected result given that the predicted WaaP proteins of
S. enterica and E. coli F470 are 81.5% identical
(90.6% similar).

View larger version (115K):
[in this window]
[in a new window]
|
FIG. 2.
Silver-stained SDS-polyacrylamide gels showing the LPS
profiles of strains ATCC 14028 (lane 1), CWG304 (lane 2), and CWG304
complemented with the waaP open reading frame from E. coli F470 (lane 3). Samples were run on a 10 to 20% Tricine
SDS-polyacrylamide gel (A) and on a standard SDS-12% polyacrylamide
gel (B). The gel system in panel A gives better resolution of
low-molecular-weight LPS (i.e., LPS lacking O antigen), while the
standard gel system shows that the modality of O-antigen expression is
unaffected in the mutant strain. The migration of Ra-LPS (lipid A and
complete core) in each gel system is indicated by an arrow. Note that
Ra-LPS comigrates with LPS molecules with one O-antigen repeat in the
gel system in panel B, so the amount of free (uncapped) lipid A-core is
misleading. The extent of capping is clear in panel A.
|
|
Phosphorylation of the inner core heptose region in CWG304 was then
examined by 31P NMR and methylation linkage analysis. The
31P NMR spectra of the core oligosaccharides from the
wild-type parent and the waaP-null strain are shown in Fig.
3. The signal at approximately 5 ppm in
the parent spectrum corresponds to the phosphate residues on HepI and
HepII, while the doublet at approximately
10 ppm corresponds to PPEtN
on HepI (16, 17, 25, 43). The complete lack of phosphate in
the CWG304 core is shown by the disappearance of all phosphorus signals
(compare Fig. 3A and B).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 3.
31P NMR spectra of the core oligosaccharides
from ATCC 14028 (A) and CWG304 (B). The signal at 5 ppm is indicative
of a phosphomonoester (P on either HepI or HepII), and the two peaks
near 10 ppm are characteristic of a diphosphodiester (PPEtN on HepI)
(16).
|
|
Methylation linkage analysis of the LPS core oligosaccharides from ATCC
14028 and CWG304 further confirmed the predicted structure of the
mutant core (Table 1). Derivatives from
HepI [
3)-Hep4P(PEtN)-(1
] or HepII [
3,7)-Hep4P-(1
] were
not evident for ATCC 14028 LPS because the phosphoryl substituents
attached to these residues make their derivatives too polar to elute
from the gas-liquid chromatography column, as established previously
with E. coli (43). Analysis of the CWG304 core
showed the disappearance of the HepIII [Hep-(1
] derivative and the
appearance of a derivative corresponding to 3-substituted heptose
[
3)-Hep-(1
] (Table 1). The 3-substituted heptose derivative
reflects both nonphosphorylated HepI and nonphosphorylated HepII
lacking the branch HepIII residue (Table 1). Together with our
31P NMR results, these data confirm the predicted
structural defect caused by the waaP mutation (Fig. 1B).
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Methylation linkage analysis of the core oligosaccharide
heptose regions from the LPSs of ATCC 14028 and CWG304
|
|
Influence of the waaP mutation on sensitivity to
antimicrobial compounds.
To confirm the predicted sensitivity of
CWG304 to hydrophobic compounds (as part of the deep-rough phenotype),
the strain's susceptibility to SDS and novobiocin was tested. CWG304
exhibited more than a 125-fold increase in susceptibility to SDS and
more than a 30-fold increase in susceptibility to novobiocin compared to the parent strain (Table 2).
Complementation with plasmid pWQ909, carrying waaP from
E. coli F470, restored wild-type levels of resistance to
these compounds. The MIC results for PM susceptibility testing are also
summarized in Table 2. In the absence of the waaP defect,
the PmrA-constitutive strain shows increased resistance to PM (compare
ATCC 14028 and JSG435), as reported previously (9). The
waaP mutation, however, causes a clear increase in PM
sensitivity. In the wild-type background, the PM MIC is decreased by
100-fold (compare ATCC 14028 and CWG304), while a somewhat smaller
decrease (8-fold) is observed in the PmrA-constitutive background
(compare JSG435 and JSG778).
To address whether the changes in PM susceptibility were related to or
independent of lipid A aminoarabinose substitution, the lipid A of each
LPS was analyzed by MALDI-TOF mass spectrometry (Fig.
4). The mass spectra of the lipids A from
ATCC 14028 and CWG304 show no significant differences in hexa- and
hepta-acylated forms (Fig. 4). Peaks for aminoarabinose-substituted
lipid A are not evident in the wild-type background because this
substitution occurs only at very low levels (11). The
spectra of the parent and waaP mutant strains in the
PmrA-constitutive background (JSG435 and JSG778) are also essentially
identical (Fig. 4). However, of particular note in the
PmrA-constitutive background, mutation of waaP does not
affect lipid A aminoarabinose substitution. Peaks corresponding to
aminoarabinose-substituted hexa- and hepta-acylated lipid A
(m/z 1928 and 2167) are present in the same ratios in both
the JSG435 and JSG778 spectra. It was therefore concluded that the
contribution of core phosphate residues to PM resistance is distinct
from the effects of lipid A aminoarabinose modification.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 4.
Characterization of structural modifications of S. enterica lipid A by negative-ion MALDI-TOF mass spectrometry. All
values given are average masses rounded to the nearest whole number for
singly charged, deprotonated molecules [M H] .
(A) ATCC 14028 (parent) lipid A, with the major signal representing the
hexa-acylated form (at m/z 1797). The hepta-acylated form
containing palmitate (at m/z 2036) is indicated. (B) CWG304
(waaP::aacC1) lipid A, showing ions at
m/z 1797 and 2036 as described above. (C) JSG435
(pmrA505) lipid A, showing the hexa- and hepta-acylated
forms (as described above), as well as modification by the addition of
aminoarabinose (m/z 1928 and 2167, respectively) or by the
addition of a hydroxyl group (m/z 1814 and 2052, respectively). (D) JSG778 (pmrA505
waaP::aacC1) lipid A, showing ions at
m/z 1797, 1814, 1928, 2036, 2052, and 2167 as described
above.
|
|
Effect of the waaP mutation on growth and
virulence.
Given the profound changes in outer membrane
composition caused by the waaP mutation, we performed growth
curve determinations for ATCC 14028 and CWG304 to determine if mutation
of waaP affected basic growth characteristics. Somewhat
surprisingly, the growth curves of the wild type and the
waaP mutant (in Luria-Bertani broth at 37°C) were
identical (data not shown).
To then assess whether the virulence of CWG304 was altered in vivo,
three different mouse strains (C57BL/6J, A/J, and BALB/c) were used.
Both C57BL/6J and BALB/c are extremely susceptible to S. enterica infection due to a mutation in the Nramp1 gene (38), while the wild-type strain A/J is naturally more
resistant to infection. The resistant A/J mice were unaffected by
challenge with either 102 or 103 CFU of ATCC
14028 (administered by injection in the caudal vein). At
104 CFU, three of five mice died after 15 days. The
remaining mice survived over the 21-day course of the experiment. All
of the highly susceptible C57BL/6J mice died within 5 days at
103 or 104 CFU and within 6 days at
102 CFU (as expected). By contrast, all of the mice (both
strains) challenged with the waaP mutant strain survived (at
all doses and for the duration of the experiment).
The surviving A/J mice were euthanized on day 21, and spleen and liver
homogenates were plated to determine the extent of persisting S. enterica infection (Table 3). In
mice challenged with ATCC 14028, the bacteria could still be isolated
from the liver and spleen homogenates in significant numbers. However, CWG304 bacteria were virtually cleared by day 21 and could be detected
only in very small numbers in the spleen at the highest dose
administered.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Average numbers of CFU in the spleens and livers of A/J
mice challenged intravenously with the indicated doses of ATCC
14028 or CWG304a
|
|
Given the somewhat decreased amount of O-antigen expression in strain
CWG304, as observed by SDS-PAGE (Fig. 2), it was possible that the
mutant's loss of virulence could be attributed to an increase in
susceptibility to complement-mediated serum killing. O antigen is known
to be an important factor in the ability of many bacteria to evade
complement (21). To determine whether bacteria injected into
the bloodstream were simply cleared by complement-mediated cell lysis,
the parent and waaP mutant strains were incubated with fresh
mouse serum for 2 h at 37°C, and then serial dilutions were
plated on Luria-Bertani agar plates. No difference in CFU was observed
between the two strains (data not shown), indicating that
complement-mediated killing is likely not a factor in inhibiting CWG304 infection.
Finally, to determine whether the loss of virulence in CWG304 was
influenced by the route of infection, BALB/c mice were challenged with
ATCC 14028 and CWG304, both orally and by intraperitoneal injection.
These models are the most widely accepted for S. enterica virulence studies, and 50% lethal doses (LD50s) have been
determined for both methods (6.5 × 104 and <10 for
oral and intraperitoneal infection, respectively) (3). The
results from the oral and intraperitoneal infection experiments show
that the virulence defect of CWG304 does not depend on how the inoculum
is administered: all of the mice infected with CWG304 (n = 5 to 10) survived at a dose of 10 times the LD50 (intraperitoneally) or 100 times the LD50 (orally), while
all of the mice challenged with the wild-type ATCC 14028 died at these doses.
 |
DISCUSSION |
Strain CWG304 is the first S. enterica waaP mutant to
be characterized both genetically and structurally. Earlier
"waaP mutants" of S. enterica serovar
Typhimurium were obtained using chemical mutagenesis and phage
selection, and are all reported to be leaky, with small amounts of
phosphate still detectable in the core (18). CWG304,
however, is known to be nonleaky because of the nature of the mutation
(see Materials and Methods) and the complete lack of phosphate in its
core region as observed by 31P NMR (Fig. 3), the most
sensitive detection method available. As such, the creation of our
waaP mutant of S. enterica refutes the earlier
conclusion that such mutations in S. enterica must be leaky
to maintain viability. Further, the
waaP::aacC1 mutation could be
transduced by P22 into a clean S. enterica serovar
Typhimurium background, giving a strain with the same deep-rough
phenotype (J. A. Yethon, J. S. Gunn, and C. Whitfield,
unpublished data). This argues against the possibility of unlinked
secondary, compensating mutations. Strain CWG304 therefore represents a
valuable tool for dissection of the various factors involved in
antibiotic sensitivities (i.e., changes in core phosphorylation versus
core truncation and the presence or absence of O antigen).
Interestingly, our waaP mutant strain shows a slightly
decreased efficiency of core completion and capping with O antigen
(Fig. 2), but this difference is not enough to cause any increase in
susceptibility to complement-mediated serum killing. There is no
obvious change in maximal O-chain length or modal distribution of O
antigen. Therefore, the waaP mutant is essentially a smooth
strain that expresses characteristics of the deep-rough phenotype,
clearly demonstrating that it is the lack of core phosphate and not
core truncation that causes this phenotype.
The effects of various LPS core defects on antibiotic susceptibilities
in S. enterica have been examined previously
(27), but the genes mutated were not precisely defined.
Therefore, it is difficult to compare our results directly with those
of these earlier studies. However, S. enterica mutants with
highly truncated cores were previously shown to be more susceptible
to numerous antibiotics, including PM (27). In light of the
findings reported here, and given the observation that E. coli mutants lacking the outer core glycoses are affected in their
degree of heptose phosphorylation (J. A. Yethon, E. V. Vinogradov, M. B. Perry, and C. Whitfield, submitted for
publication), it is concluded that LPS core phosphate residues are
essential to the outer membrane barrier function of S. enterica and in particular to PM resistance.
The interaction between cationic antimicrobial peptides and the
gram-negative outer membrane is complex (reviewed in references 14, 24, and 36). Indeed, there
appear to be distinct modifications required for resistance to
different cationic antimicrobial compounds (10, 12). The
increased PM susceptibility of S. enterica waaP mutants
brings into question the current dogma that PM resistance is mediated
by LPS charge modulation alone. It appears instead, at least in the
case of a waaP mutation, that detrimental hydrophobic interactions between PM and the outer membrane can outweigh the benefits associated with a decrease in LPS net negative charge. This
does not mean that electrostatic interactions are not important. It has
been proposed, for example, that PM functions by a detergent-like mechanism, requiring numerous PM molecules to aggregate into clusters at the outer membrane surface (42). Clearly, electrostatic
interactions would favor the accumulation of PM molecules at the outer
membrane surface and thus facilitate the formation of such clusters.
However, our studies and the work of others (33) suggest
that hydrophobic interactions may play a critical role in the PM-LPS interaction.
Our data must be interpreted with caution, however, because there is
evidence that other defects (not related to LPS structure) in the outer
membrane of deep-rough mutants might influence the membrane barrier
function in unexpected ways. For example, there are regions of
phospholipid bilayer in the outer membranes of deep-rough mutants
(22), although the extent of these regions is not known. One
hypothesis, proposed by Nikaido and Vaara (24), suggests
that these regions of phospholipid bilayer are responsible for the
increased susceptibility of deep-rough mutants to hydrophobic agents.
Therefore, the increased PM sensitivity of our S. enterica waaP mutant might be the result of PM simply passing through
phospholipid-enriched domains in the outer membrane and not interacting
with LPS at all. However, the surface area occupied by these
phospholipid domains is estimated to be small (24), and
given the fact that a PmrA-constitutive strain can still upregulate PM
resistance despite carrying a waaP mutation (compare CWG304
and JSG778 in Table 1), we feel that this is likely not the case.
Finally, regardless of the exact mechanism by which mutation of
waaP affects the outer membrane, we have shown that such a mutation leads to avirulence in vivo. Loss of virulence was
demonstrated by both the survival of C57BL/6J and BALB/c mice and the
decrease in CFU in the spleens and livers of infected A/J mice (Table
3). In addition, the virulence defect was shown for intravenous,
intraperitoneal, and oral administration of the inoculum. Given the
greatly compromised barrier function of the mutant outer membrane and
the avirulence of the mutant in our mouse infection model, we believe
that the waaP gene product represents a valid potential
target for the development of novel therapeutics. Interestingly, a WaaP
homolog was recently identified in P. aeruginosa, an
important opportunistic pathogen in the lungs of individuals with
cystic fibrosis. The initial identification of WaaP in P. aeruginosa was made based on homology (>60% similarity) to WaaP
from E. coli and S. enterica, and the available
evidence suggests that WaaP is essential for the viability of P. aeruginosa in vitro (39). Therefore, an inhibitor
targeted against WaaP would be active against a range of bacteria
extending beyond members of the family Enterobacteriaceae.
We thank M. A. Monteiro and M. B. Perry (Institute for
Biological Sciences, National Research Council, Ottawa, Ontario,
Canada) for assistance with the chemical analyses of the LPS core
oligosaccharides and W. Woodward (University of Guelph, Guelph,
Ontario, Canada) for mouse serum.
This work was supported in part through funding to C.W. and D.M. by the
Canadian Bacterial Diseases Network (Network of Centres of Excellence).
J.A.Y. is the recipient of graduate scholarships from the Natural
Sciences and Engineering Research Council and from the Medical Research
Council of Canada. J.S.G. was supported by a grant from the National
Institutes of Health (AI43521). D.M. is a Scholar of Fonds de la
Recherche en Santé du Québec (FRSQ).
| 1.
|
Amor, P. A., and C. Whitfield.
1997.
Molecular and functional analysis of genes required for expression of group IB K antigens in Escherichia coli: characterization of the his-region containing gene clusters for multiple cell-surface polysaccharides.
Mol. Microbiol.
26:145-161[CrossRef][Medline].
|
| 2.
|
Appelmelk, B. J.,
B. Shiberu,
C. Trinks,
N. Tapsi,
P. Y. Zheng,
T. Verboom,
J. Maaskant,
C. H. Hokke,
W. E. Schiphorst,
D. Blanchard,
I. M. Simoons-Smit,
D. H. van den Eijnden, and C. M. Vandenbroucke-Grauls.
1998.
Phase variation in Helicobacter pylori lipopolysaccharide.
Infect. Immun.
66:70-76[Abstract/Free Full Text].
|
| 3.
|
Behlau, I., and S. I. Miller.
1993.
A PhoP-repressed gene promotes Salmonella typhimurium invasion of epithelial cells.
J. Bacteriol.
175:4475-4484[Abstract/Free Full Text].
|
| 4.
|
Caroff, M.,
A. Tacken, and L. Szabo.
1988.
Detergent-accelerated hydrolysis of bacterial endotoxins and determination of the anomeric configuration of the glycosyl phosphate present in the "isolated lipid A" fragment of the Bordetella pertussis endotoxin.
Carbohydr. Res.
175:273-282[CrossRef][Medline].
|
| 5.
|
Ciucanu, I., and F. Kerek.
1984.
A simple and rapid method for the permethylation of carbohydrates.
Carbohydr. Res.
131:209-217[CrossRef].
|
| 6.
|
de Cock, H.,
K. Brandenburg,
A. Wiese,
O. Holst, and U. Seydel.
1999.
Non-lamellar structure and negative charges of lipopolysaccharides required for efficient folding of outer membrane protein PhoE of Escherichia coli.
J. Biol. Chem.
274:5114-5119[Abstract/Free Full Text].
|
| 7.
|
Ernst, R. K.,
E. C. Yi,
L. Guo,
K. B. Lim,
J. L. Burns,
M. Hackett, and S. I. Miller.
1999.
Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa.
Science
286:1561-1565[Abstract/Free Full Text].
|
| 8.
|
Govoni, G.,
F. Canonne-Hergaux,
C. G. Pfeifer,
S. L. Marcus,
S. D. Mills,
D. J. Hackman,
S. Grinstein,
D. Malo,
B. B. Finlay, and P. Gros.
1999.
Functional expression of Nramp1 in vitro in the murine macrophage line RAW264.7.
Infect. Immun.
67:2225-2232[Abstract/Free Full Text].
|
| 9.
|
Gunn, J. S.,
K. B. Lim,
J. Krueger,
K. Kim,
L. Guo,
M. Hackett, and S. I. Miller.
1998.
PmrA PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance.
Mol. Microbiol.
27:1171-1182[CrossRef][Medline].
|
| 10.
|
Gunn, J. S., and S. I. Miller.
1996.
PhoP-PhoQ activates transcription of pmrAB, encoding a two-component regulatory system involved in Salmonella typhimurium antimicrobial peptide resistance.
J. Bacteriol.
178:6857-6864[Abstract/Free Full Text].
|
| 11.
|
Guo, L.,
K. B. Lim,
J. S. Gunn,
B. Bainbridge,
R. P. Darveau,
M. Hackett, and S. I. Miller.
1997.
Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ.
Science
276:250-253[Abstract/Free Full Text].
|
| 12.
|
Guo, L.,
K. B. Lim,
C. M. Poduje,
M. Daniel,
J. S. Gunn,
M. Hackett, and S. I. Miller.
1998.
Lipid A acylation and bacterial resistance against vertebrate antimicrobial peptides.
Cell
95:189-198[CrossRef][Medline].
|
| 13.
|
Hamilton, C. A.,
M. Aldea,
B. K. Washburn,
P. Babtizke, and S. R. Kushner.
1989.
New method of generating deletions and gene replacements in Escherichia coli.
J. Bacteriol.
171:4617-4622[Abstract/Free Full Text].
|
| 14.
|
Hancock, R. E., and D. S. Chapple.
1999.
Peptide antibiotics.
Antimicrob. Agents Chemother.
43:1317-1323[Free Full Text].
|
| 15.
|
Heinrichs, D. E.,
J. A. Yethon, and C. Whitfield.
1998.
Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica.
Mol. Microbiol.
30:221-232[CrossRef][Medline].
|
| 16.
|
Helander, I. M.,
I. Kilpeläinen, and M. Vaara.
1994.
Increased substitution of phosphate groups in lipopolysaccharides and lipid A of the polymyxin-resistant pmrA mutants of Salmonella typhimurium: a 31P-NMR study.
Mol. Microbiol.
11:481-487[CrossRef][Medline].
|
| 17.
|
Helander, I. M.,
I. Kilpeläinen, and M. Vaara.
1997.
Phosphate groups in lipopolysaccharides of Salmonella typhimurium rfaP mutants.
FEBS Lett.
409:457-460[CrossRef][Medline].
|
| 18.
|
Helander, I. M.,
M. Vaara,
S. Sukupolvi,
M. Rhen,
S. Saarela,
U. Zähringer, and P. H. Mäkelä.
1989.
rfaP mutants of Salmonella typhimurium.
Eur. J. Biochem.
185:541-546[Medline].
|
| 19.
|
Hitchcock, P. J., and T. M. Brown.
1983.
Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.
J. Bacteriol.
154:269-277[Abstract/Free Full Text].
|
| 20.
|
Holst, O., and H. Brade.
1992.
Chemical structure of the core region of lipopolysaccharides, p. 134-170.
In
D. C. Morrison, and J. L. Ryan (ed.), Bacterial endotoxic lipopolysaccharides, vol. I. CRC Press, Boca Raton, Fla.
|
| 21.
|
Joiner, K. A.
1988.
Complement evasion by bacteria and parasites.
Annu. Rev. Microbiol.
42:201-230[CrossRef][Medline].
|
| 22.
|
Kamio, Y., and H. Nikaido.
1976.
Outer membrane of Salmonella typhimurium: accessibility of phospholipid head groups to phospholipase C and cyanogen bromide activated dextran in the external medium.
Biochemistry
15:2561-2570[CrossRef][Medline].
|
| 23.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
Nature
227:680-685[CrossRef][Medline].
|
| 24.
|
Nikaido, H., and M. Vaara.
1985.
Molecular basis of bacterial outer membrane permeability.
Microbiol. Rev.
49:1-32[Free Full Text].
|
| 25.
|
Olsthoorn, M. M. A.,
B. O. Petersen,
S. Schlecht,
J. Haverkamp,
K. Bock,
J. E. Thomas-Oates, and O. Holst.
1998.
Identification of a novel core type in Salmonella lipopolysaccharide. Complete structural analysis of the core region of the lipopolysaccharide from Salmonella enterica sv. Arizonae O62.
J. Biol. Chem.
273:3817-3829[Abstract/Free Full Text].
|
| 26.
|
Raetz, C. R. H.
1996.
Bacterial lipopolysaccharides: a remarkable family of bioactive macroamphiphiles, p. 1035-1063.
In
F. C. Neidhardt, R. Curtiss III, J. L. Ingraham, E. C. C. Lin, K. B. Low, B. Magasanik, W. S. Reznikoff, M. Riley, M. Schaechter, and H. E. Umbarger (ed.), Escherichia coli and Salmonella: cellular and molecular biology, vol. 1. ASM Press, Washington, D.C.
|
| 27.
|
Roantree, R. J.,
T.-T. Kuo, and D. G. MacPhee.
1977.
The effect of defined lipopolysaccharide core defects upon antibiotic resistances of Salmonella typhimurium.
J. Gen. Microbiol.
103:223-234[Medline].
|
| 28.
|
Roland, K. L.,
L. E. Martin,
C. R. Esther, and J. K. Spitznagel.
1993.
Spontaneous pmrA mutants of Salmonella typhimurium LT2 define a new two-component regulatory system with a possible role in virulence.
J. Bacteriol.
175:4154-4164[Abstract/Free Full Text].
|
| 29.
|
Schnaitman, C. A., and J. D. Klena.
1993.
Genetics of lipopolysaccharide biosynthesis in enteric bacteria.
Microbiol. Rev.
57:655-682[Abstract/Free Full Text].
|
| 30.
|
Schweizer, H. P.
1993.
Small broad-host-range gentamycin resistance cassettes for site-specific insertion and deletion mutagenesis.
BioTechniques
15:831-833[Medline].
|
| 31.
|
Sebastiani, G.,
L. Olien,
S. Gauthier,
E. Skamene,
K. Morgan,
P. Gros, and D. Malo.
1998.
Mapping of genetic modulators of natural resistance to infection with Salmonella typhimurium in wild-derived mice.
Genomics
47:180-186[CrossRef][Medline].
|
| 32.
|
Shafer, W. M.,
L. E. Martin, and J. K. Spitznagel.
1984.
Cationic antimicrobial proteins isolated from human neutrophil granulocytes in the presence of diisopropyl fluorophosphate.
Infect. Immun.
45:29-35[Abstract/Free Full Text].
|
| 33.
|
Srimal, S.,
N. Surolia,
S. Balasubramanian, and A. Surolia.
1996.
Titration calorimetric studies to elucidate the specificity of the interactions of polymyxin B with lipopolysaccharides and lipid A.
Biochem. J.
315:679-686.
|
| 34.
|
Steinberg, D. A.,
M. A. Hurst,
C. A. Fujii,
A. H. Kung,
J. F. Ho,
F. C. Cheng,
D. J. Loury, and J. C. Fiddes.
1997.
Protegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity.
Antimicrob. Agents Chemother.
41:1738-1742[Abstract].
|
| 35.
|
Tsai, G. M., and C. E. Frasch.
1982.
A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels.
Anal. Biochem.
119:115-119[CrossRef][Medline].
|
| 36.
|
Vaara, M.
1992.
Agents that increase the permeability of the outer membrane.
Microbiol. Rev.
56:395-411[Abstract/Free Full Text].
|
| 37.
|
van Putten, J. P. M., and B. D. Robertson.
1995.
Molecular mechanisms and implications for infection of lipopolysaccharide variation in Neisseria.
Mol. Microbiol.
16:847-853[CrossRef][Medline].
|
| 38.
|
Vidal, S.,
M. L. Tremblay,
G. Govoni,
S. Gauthier,
G. Sebastiani,
D. Malo,
E. Skamene,
M. Olivier,
S. Jothy, and P. Gros.
1995.
The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene.
J. Exp. Med.
182:655-666[Abstract/Free Full Text].
|
| 39.
|
Walsh, A. G.,
M. J. Matewish,
L. L. Burrows,
M. A. Monteiro,
M. B. Perry, and J. S. Lam.
2000.
Lipopolysaccharide core phosphates are required for viability and intrinsic drug resistance in Pseudomonas aeruginosa.
Mol. Microbiol.
35:718-727[CrossRef][Medline].
|
| 40.
|
Weiser, J. N., and N. Pan.
1998.
Adaptation of Haemophilus influenzae to acquired and innate humoral immunity based on phase variation of lipopolysaccharide.
Mol. Microbiol.
30:767-775[CrossRef][Medline].
|
| 41.
|
Westphal, O., and K. Jann.
1965.
Bacterial lipopolysaccharide extraction with phenol-water and further applications of the procedure.
Methods Carbohydr. Chem.
5:83-91.
|
| 42.
|
Wiese, A.,
M. Münstermann,
T. Gutsmann,
B. Lindner,
K. Kawahara,
U. Zähringer, and U. Seydel.
1998.
Molecular mechanisms of polymyxin B-membrane interactions: direct correlation between surface charge density and self-promoted transport.
J. Membr. Biol.
162:127-138[CrossRef][Medline].
|
| 43.
|
Yethon, J. A.,
D. E. Heinrichs,
M. A. Monteiro,
M. B. Perry, and C. Whitfield.
1998.
Involvement of waaY, waaQ, and waaP in the modification of Escherichia coli lipopolysaccharide and their role in the formation of a stable outer membrane.
J. Biol. Chem.
273:26310-26316[Abstract/Free Full Text].
|